Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of Modified Process Hepatitis B Vaccine in Renal Patients
NCT00440297Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2006
- Primary completion
- May 2008
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
01
Overview
A Phase 3 trial of Hepatitis B vaccine in hepatitis B (HBV), sponsored by Merck & Co.. Started Dec 2006; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00440297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00440297.